Skip to main content

Animations

MJFF Publications

6091 - 6100 of 6451 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2026
  • 2025
  • 2024
  • 2020
  • 2016
  • 2022
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Cortical disinhibition in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa274
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-021-00892-7
    Citation Count: 27
  • Summary Details
    OPEN
    Title: A cross-sectional exploration of the relationship between Parkinson's disease and peripheral blood immune cells in an ethnically diverse East London population
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2026.125785
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Design considerations for C9orf72 disease prevention trials
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf290
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive function
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107229
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a‐synuclein in mouse brain
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.15199
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Problematic Mobile Gaming in Parkinson's Disease: An Impulse Control Disorder for the Smartphone
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12378
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Progression of regional cortical cholinergic denervation in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac320
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette Syndrome
    Journal Name: Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.bpsc.2020.11.005
    Citation Count: 42
  • Summary Details
    OPEN
    Title: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202000768
    Citation Count: 129
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.